{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hérédité multifactorielle : Questions médicales les plus fréquentes",
"headline": "Hérédité multifactorielle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hérédité multifactorielle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-27",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hérédité multifactorielle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Modes de transmission héréditaire",
"url": "https://questionsmedicales.fr/mesh/D040582",
"about": {
"@type": "MedicalCondition",
"name": "Modes de transmission héréditaire",
"code": {
"@type": "MedicalCode",
"code": "D040582",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.420"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hérédité multifactorielle",
"alternateName": "Multifactorial Inheritance",
"code": {
"@type": "MedicalCode",
"code": "D020412",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zexuan Zhu",
"url": "https://questionsmedicales.fr/author/Zexuan%20Zhu",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Muhammad Umar Nasir",
"url": "https://questionsmedicales.fr/author/Muhammad%20Umar%20Nasir",
"affiliation": {
"@type": "Organization",
"name": "Riphah School of Computing & Innovation, Faculty of Computing, Riphah International University Lahore Campus, Lahore 54000, Pakistan."
}
},
{
"@type": "Person",
"name": "Mohammed Gollapalli",
"url": "https://questionsmedicales.fr/author/Mohammed%20Gollapalli",
"affiliation": {
"@type": "Organization",
"name": "Department of Computer Information Systems, College of Computer Science and Information Technology, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia."
}
},
{
"@type": "Person",
"name": "Muhammad Adnan Khan",
"url": "https://questionsmedicales.fr/author/Muhammad%20Adnan%20Khan",
"affiliation": {
"@type": "Organization",
"name": "Pattern Recognition and Machine Learning Lab, Department of Software, Gachon University, Seongnam, Gyeonggido 13120, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Kord M Kober",
"url": "https://questionsmedicales.fr/author/Kord%20M%20Kober",
"affiliation": {
"@type": "Organization",
"name": "University of California, San Francisco."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Platelet Glycoprotein IIIa",
"datePublished": "2024-03-16",
"url": "https://questionsmedicales.fr/article/38550545",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14740/jocmr5094"
}
},
{
"@type": "ScholarlyArticle",
"name": "Decreased Platelet Specific Receptor Expression of P-Selectin and GPIIb/IIIa Predict Future Non-Surgical Bleeding in Patients after Left Ventricular Assist Device Implantation.",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/36142161",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms231810252"
}
},
{
"@type": "ScholarlyArticle",
"name": "Potential Mechanism of Platelet GPIIb/IIIa and Fibrinogen on Retinal Vein Occlusion.",
"datePublished": "2024-03-14",
"url": "https://questionsmedicales.fr/article/38482878",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/02713683.2024.2327055"
}
},
{
"@type": "ScholarlyArticle",
"name": "RGD and Scutellarin Conjugate (WK001) Targeting Platelet Glycoprotein IIb/IIIa Receptor Protects from Myocardial Ischemia/Reperfusion Injury: Synthesis, Characterization, and Bioactivity Evaluation.",
"datePublished": "2023-02-05",
"url": "https://questionsmedicales.fr/article/36740781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.bioconjchem.2c00439"
}
},
{
"@type": "ScholarlyArticle",
"name": "An Updated Review on Glycoprotein IIb/IIIa Inhibitors as Antiplatelet Agents: Basic and Clinical Perspectives.",
"datePublished": "2023-01-13",
"url": "https://questionsmedicales.fr/article/36637623",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40292-023-00562-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Modes de transmission héréditaire",
"item": "https://questionsmedicales.fr/mesh/D040582"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hérédité multifactorielle",
"item": "https://questionsmedicales.fr/mesh/D020412"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hérédité multifactorielle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hérédité multifactorielle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hérédité multifactorielle",
"description": "Comment diagnostiquer une maladie multifactorielle ?\nQuels tests sont utilisés pour le diagnostic ?\nLes antécédents familiaux sont-ils importants ?\nPeut-on identifier des marqueurs génétiques ?\nQuel rôle joue la génétique dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Platelet+Glycoprotein+GPIIb-IIIa+Complex#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hérédité multifactorielle",
"description": "Quels sont les symptômes courants des maladies multifactorielle ?\nLes symptômes apparaissent-ils à un âge spécifique ?\nLes symptômes sont-ils similaires à d'autres maladies ?\nPeut-on avoir des symptômes sans antécédents familiaux ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Platelet+Glycoprotein+GPIIb-IIIa+Complex#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hérédité multifactorielle",
"description": "Comment prévenir les maladies multifactorielle ?\nL'éducation génétique aide-t-elle à la prévention ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nLes changements de mode de vie sont-ils efficaces ?\nLes vaccinations jouent-elles un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Platelet+Glycoprotein+GPIIb-IIIa+Complex#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hérédité multifactorielle",
"description": "Quels traitements sont disponibles pour les maladies multifactorielle ?\nLes traitements sont-ils personnalisés ?\nY a-t-il des traitements préventifs ?\nLes traitements sont-ils efficaces à long terme ?\nLes traitements peuvent-ils avoir des effets secondaires ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Platelet+Glycoprotein+GPIIb-IIIa+Complex#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hérédité multifactorielle",
"description": "Quelles complications peuvent survenir ?\nLes complications sont-elles évitables ?\nLes complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles être gérées ?\nY a-t-il des complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Platelet+Glycoprotein+GPIIb-IIIa+Complex#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hérédité multifactorielle",
"description": "Quels sont les principaux facteurs de risque ?\nL'alimentation influence-t-elle le risque ?\nLe stress est-il un facteur de risque ?\nL'exercice physique joue-t-il un rôle ?\nLes facteurs environnementaux sont-ils significatifs ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Platelet+Glycoprotein+GPIIb-IIIa+Complex#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie multifactorielle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique familial, les tests génétiques et l'évaluation clinique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques, des analyses sanguines et des examens cliniques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à évaluer le risque et à orienter le diagnostic des maladies multifactorielle."
}
},
{
"@type": "Question",
"name": "Peut-on identifier des marqueurs génétiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains marqueurs génétiques peuvent indiquer une prédisposition à des maladies spécifiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la génétique dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La génétique aide à comprendre les facteurs héréditaires contribuant à la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des maladies multifactorielle ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon la maladie, mais peuvent inclure fatigue, douleurs et anomalies physiques."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils à un âge spécifique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains symptômes peuvent se manifester à l'enfance, tandis que d'autres apparaissent à l'âge adulte."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils similaires à d'autres maladies ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent se chevaucher avec d'autres conditions, rendant le diagnostic complexe."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans antécédents familiaux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux peuvent également déclencher des symptômes sans antécédents héréditaires."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'expression des symptômes peut varier en fonction de la génétique et de l'environnement."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies multifactorielle ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un mode de vie sain, des dépistages réguliers et la gestion des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'éducation génétique aide-t-elle à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les risques génétiques peut aider les individus à prendre des décisions éclairées."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests peuvent identifier les personnes à risque et orienter les mesures préventives."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie sont-ils efficaces ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, adopter un mode de vie sain peut réduire le risque de développer certaines maladies."
}
},
{
"@type": "Question",
"name": "Les vaccinations jouent-elles un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les maladies multifactorielle."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les maladies multifactorielle ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, des thérapies physiques et des interventions chirurgicales selon la maladie."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des caractéristiques génétiques et des symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interventions préventives peuvent réduire le risque, comme des changements de mode de vie et des dépistages."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces à long terme ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité varie selon la maladie et le traitement, nécessitant un suivi régulier."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils avoir des effets secondaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comme tout traitement, il peut y avoir des effets secondaires qui doivent être surveillés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications varient selon la maladie, mais peuvent inclure des problèmes chroniques et des handicaps."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles évitables ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et une gestion appropriée."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être gérées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses complications peuvent être gérées avec des traitements appropriés et un suivi."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies multifactorielle peuvent entraîner des complications à long terme nécessitant un suivi."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hérédité, l'environnement, le mode de vie et des conditions médicales préexistantes."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée peut augmenter le risque de certaines maladies multifactorielle."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à l'apparition de maladies multifactorielle."
}
},
{
"@type": "Question",
"name": "L'exercice physique joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un manque d'exercice peut augmenter le risque de développer certaines maladies."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux sont-ils significatifs ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines et à des polluants peut augmenter le risque de maladies multifactorielle."
}
}
]
}
]
}
Department of Computer Information Systems, College of Computer Science and Information Technology, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Division of Plant Sciences and Interdisciplinary Plant Group, College of Agriculture, Food and Natural Resources, Christopher S. Bond Life Sciences Center, University of Missouri, 1201 Rollins Street, Columbia, MO, 65201, USA.
Pediatric Neurology Unit, Department of Pediatrics, Navarra Health Service Hospital, Irunlarrea 4, 310620 Pamplona, Spain; Navarrabiomed-Miguel Servet Research Foundation, Pamplona, Spain.
Neurometabolic Diseases Laboratory, IDIBELL, Hospital Duran i Reynals, Gran Via 199, 08908, L'Hospitalet de Llobregat, Barcelona, Spain; Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain; Center for Biomedical Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain. Electronic address: apujol@idibell.cat.
School of Information Technology, Skyline University College, Sharjah 1797, UAE.
Network and Communication Technology Lab, Center for Cyber Security, Faculty of Information Science and Technology, Universiti Kebangsaan, Malaysia 43600, Malaysia.
Department of Computer Science, College of Computer Science and Information Technology, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Department of Computer Science (CS), College of Computer Science and Information Technology (CCSIT), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Department of Computer, Deanship of Preparatory Year and Supporting Studies, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Genetic polymorphisms of platelet glycoprotein IIIa (...
A total of 200 participants were recruited for the study, 100 non-diabetic patients with myocardial infarction and 100 apparently healthy volunteers as a control group....
The distribution of...
The...
Non-surgical bleeding (NSB) is one of the major clinical complications in patients under continuous-flow left ventricular assist device (LVAD) support. The increased shear stress leads to an altered p...
To explore the role of coagulation and fibrinolytic factors, and the potential mechanism of platelet aggregation in the pathogenesis of retinal vein occlusion....
Coagulation and fibrinolytic parameters in patients with retinal vein occlusion were determined using hemagglutinin and HISCL-5000. Relationships between these elevated parameters and factors represen...
In patients, significant increases in peripheral blood fibrinogen and GPIIb/IIIa levels were observed (...
Fibrinogen and GPIIb/IIIa may be involved in retinal vein occlusion and blocking platelet aggregation may be a new therapeutic approach for retinal vein occlusio...
Myocardial ischemia/reperfusion (MI/R) injury is an unresolved clinical challenge. The blockade of binding fibrinogen by glycoprotein IIb/IIIa (GPIIb-IIIa) inhibitors has become a new therapeutic appr...
The glycoprotein (GP) IIb/IIIa receptor is found integrin present in platelet aggregations. GP IIb/IIIa antagonists interfere with platelet cross-linking and platelet-derived thrombus formation throug...
Morbidity and mortality related to modified Blalock-Taussig shunt (mBTTS) thrombosis remain a significant risk. Platelet inhibition following mBTTS may reduce this risk. However, oral antiplatelet age...
Retrospective, Institutional Review Board-approved cohort study....
Single-center cardiac ICU....
Patients under the age of 18 who had an mBTTS placed within the study period of January 2008 to December 2018 were included....
Patients were divided into two groups: standard of care (SOC) anticoagulation alone and SOC with tirofiban as a bridge to oral aspirin....
Freedom from mBTTS thrombosis was estimated using the Kaplan-Meier method. A multivariable predictive model using the four most significant risk factors was developed using logistic regression. A tota...
Highest risk for shunt thrombosis following mBTTS occurs within the first few days after surgical procedure. Tirofiban is a safe addition to SOC and may be an effective strategy to prevent early mBTTS...
Understanding the pharmacodynamic effects of platelet inhibitors is standard for developing more effective antithrombotic therapies. An example is the antithrombotic treatment of acute coronary syndro...
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia (XMEN) disease is a primary immunodeficiency due to loss-of-function mutations in the gene encoding for mag...
To assess platelet functions in patients with XMEN disease....
Two unrelated young boys, including one before and after hematopoietic stem cell transplantation, were investigated for their platelet functions, glycoprotein expression, and serum and platelet-derive...
Platelet analysis highlighted abnormal elongated cells and unusual barbell-shaped proplatelets. Platelet aggregation, integrin α...
Our results highlight prominent platelet dysfunction related to MAGT1 deficiency and defective N-glycosylation in several platelet proteins that could explain the hemorrhages reported in patients with...
While the efficacy of GpIIb-IIIa-inhibitors during primary PCI (pPCI) for ST-elevated myocardial infarction (STEMI) has previously been demonstrated, its ongoing role and safety in combination with ne...
In ovarian cancer, ascites represent the microenvironment in which the platelets extravasate to play their role in the disease progression. We aimed to develop an assay to measure ascites' platelet ac...